Oral Chinese traditional medicine composition for treating atrophic arthritis

Abstract

The present invention discloses a traditional Chinese medicine composition for treating rheumatoid arthritis by internal administration, which is characterized in that the parts by weight of the pharmaceutical raw materials to make the active ingredients are as follows: 10g of malaytea scurfpea fruit, 10g of rhizome, 15g of himalayan teasel root, 10g of epimedium herb, 10g of twotooth achyranthes root, 8g of roasted pangolin scales, 8g of Chinese caterpillar fungus, 8g of divaricate saposhnikovia root, 10g of prepared common monkshood daughter root, 15g of drynaria rhizome of fortune, 10g of cassia twig, 10g of white paeony root, 10g of Tibet safflower, 10g of common anemarrhena rhizome, 10g of incised notopterygium rhizome, 10g of doubleteeth pubescent angilica root, 10g of pine nodular branch, 16g of garter snake, 8g of ground beetle, 5g of ephedra herb, 8g of swordlike atractylodes rhizome, 12g of clematis root, 30g of common clubmoss herb and 10g of roasted tiger bone. The present invention is prepared into the decoction for oral administration with one dose per day. The medicine of the present invention has the effects of invigorating kidney, dispelling cold, removing dampness, dispelling wind, removing blood stasis, dredging collaterals, strengthening sinews and bones. The present invention obtains the satisfactory effect during the treatment course of rheumatoid arthritis. The clinical verification proves that the effective rate can achieve 93.6 percent.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral treatment of rheumatoid arthritis. It belongs to the field of traditional Chinese medicine. Background technique [0002] Rheumatoid arthritis (RA) is an autoimmune disease whose detailed pathogenesis is still not fully understood. It is currently known that its etiology is related to genetic and environmental factors. The majority of patients are female, and the ratio of female to male is about 3:1. The average age of onset is about 30 to 50 years old. Its prevalence is about 1%, and increases with age. In addition to invading joints, RA may also infect extra-articular organs, including salivary glands, lacrimal glands, liver, spleen, blood system, lymph glands, nervous system, heart, lungs, etc. The course of the disease varies from person to person, but most patients progress rapidly within a few years of onset (especially within the first year), and bone destruction m...

AI Technical Summary

Problems solved by technology

Although conventional western medicine has ideal anti-inflammatory and analgesic effects, it cannot improve the basic pathological changes. After stopping the medicine, the symptoms recur, or even become more serious, and become a "rebound". Moreover, long-term medication may cause adverse reactions and side effects

not fully satisfactory

Various immunotherapies are still under development, and the effects need to be further evaluated